ALI SAJJAD MD
Prescription History 1619913621
Internal Medicine - Rheumatology in Maplewood, MN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ALI SAJJAD MD, an active Rheumatology specialist practicing in Maplewood, MN. Our medical registry currently tracks 23 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,399 documented patient claims. Among these therapy options, the most frequently utilized medication is Methotrexate, which accounts for 823 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MN PrescribersVs. MN Avg |
|---|---|---|---|
| MethotrexateMethotrexate Sodium | 823 | $70.48 | ▲ More than typical |
About Methotrexate: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma) or to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. Show more ▾ It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. In 2023, this provider wrote 823 Medicare prescriptions for Methotrexate, about 9.1 times the volume of the typical Minnesota prescriber of this medication (90). Medicare paid an average of $70.48 per fill, versus $60.90 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,893.1 30-Day Fills standardized to 30-day supplies 55,890 Days of Medication total across all patients in 2023 | |||
| Hydroxychloroquine Sulfate | 679 | $111.69 | ▲ More than typical |
About Hydroxychloroquine Sulfate: Hydroxychloroquine is used to prevent or treat malaria caused by mosquito bites. Show more ▾ The United States Center for Disease Control provides updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs. This medication is also used to treat certain auto-immune diseases (lupus, rheumatoid arthritis). It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs). It can reduce skin problems in lupus and prevent swelling/pain in arthritis. Hydroxychloroquine is not recommended for coronavirus infection, also known as COVID-19, unless you are enrolled in a study. Talk to your doctor about the risks and benefits. A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) In 2023, this provider wrote 679 Medicare prescriptions for Hydroxychloroquine Sulfate, about 9.4 times the volume of the typical Minnesota prescriber of this medication (72). Medicare paid an average of $111.69 per fill, versus $84.96 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,703 30-Day Fills standardized to 30-day supplies 51,022 Days of Medication total across all patients in 2023 | |||
| Prednisone | 374 | $12.51 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 374 Medicare prescriptions for Prednisone, about 9.4 times the volume of the typical Minnesota prescriber of this medication (40). Medicare paid an average of $12.51 per fill, versus $7.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 581.8 30-Day Fills standardized to 30-day supplies 15,852 Days of Medication total across all patients in 2023 | |||
| Duloxetine Hcl | 323 | $58.37 | ▲ More than typical |
About Duloxetine Hcl: Duloxetine is used to treat depression and anxiety. Show more ▾ In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA. In 2023, this provider wrote 323 Medicare prescriptions for Duloxetine Hcl, about 6.9 times the volume of the typical Minnesota prescriber of this medication (47). Medicare paid an average of $58.37 per fill, versus $49.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 684 30-Day Fills standardized to 30-day supplies 20,466 Days of Medication total across all patients in 2023 | |||
| Leflunomide | 259 | $124.63▼ below MN avg | ▲ More than typical |
About Leflunomide: This medication is used to treat rheumatoid arthritis, a condition in which the body's defense system (immune system) fails to recognize the body as itself and attacks the healthy tissues around the joints. Show more ▾ Leflunomide helps to reduce the joint damage/pain/swelling and helps you to move better. It works by weakening your immune system and decreasing swelling (inflammation). An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS. In 2023, this provider wrote 259 Medicare prescriptions for Leflunomide, about 4.3 times the volume of the typical Minnesota prescriber of this medication (60). Medicare paid an average of $124.63 per fill, versus $126.66 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MN average for this medication. 541.6 30-Day Fills standardized to 30-day supplies 16,159 Days of Medication total across all patients in 2023 | |||
| Allopurinol | 162 | $26.31 | ▲ More than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2023, this provider wrote 162 Medicare prescriptions for Allopurinol, about 3.8 times the volume of the typical Minnesota prescriber of this medication (43). Medicare paid an average of $26.31 per fill, versus $16.19 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 447.2 30-Day Fills standardized to 30-day supplies 13,393 Days of Medication total across all patients in 2023 | |||
| Sulfasalazine | 160 | $49.81 | ▲ More than typical |
About Sulfasalazine: Sulfasalazine is used to treat a certain type of bowel disease called ulcerative colitis. Show more ▾ This medication does not cure this condition, but it helps decrease symptoms such as fever, stomach pain, diarrhea, and rectal bleeding. After an attack is treated, sulfasalazine is also used to increase the amount of time between attacks. This medication works by reducing irritation and swelling in the large intestines. In addition, delayed-release tablets of sulfasalazine are used to treat rheumatoid arthritis. Sulfasalazine helps to reduce joint pain, swelling, and stiffness. Early treatment of rheumatoid arthritis with sulfasalazine helps to reduce/prevent further joint damage so you can do more of your normal daily activities. This medication is used with other drugs, rest, and physical therapy in patients who have not responded to other medications (salicylates, nonsteroidal anti-inflammatory drugs-NSAIDs). A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) In 2023, this provider wrote 160 Medicare prescriptions for Sulfasalazine, about 5.2 times the volume of the typical Minnesota prescriber of this medication (31). Medicare paid an average of $49.81 per fill, versus $40.55 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 392.8 30-Day Fills standardized to 30-day supplies 11,739 Days of Medication total across all patients in 2023 | |||
| Sulfasalazine DrSulfasalazine | 107 | $58.06▼ below MN avg | ▲ More than typical |
About Sulfasalazine Dr: Sulfasalazine is used to treat a certain type of bowel disease called ulcerative colitis. Show more ▾ This medication does not cure this condition, but it helps decrease symptoms such as fever, stomach pain, diarrhea, and rectal bleeding. After an attack is treated, sulfasalazine is also used to increase the amount of time between attacks. This medication works by reducing irritation and swelling in the large intestines. In addition, delayed-release tablets of sulfasalazine are used to treat rheumatoid arthritis. Sulfasalazine helps to reduce joint pain, swelling, and stiffness. Early treatment of rheumatoid arthritis with sulfasalazine helps to reduce/prevent further joint damage so you can do more of your normal daily activities. This medication is used with other drugs, rest, and physical therapy in patients who have not responded to other medications (salicylates, nonsteroidal anti-inflammatory drugs-NSAIDs). A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) In 2023, this provider wrote 107 Medicare prescriptions for Sulfasalazine Dr, about 4.1 times the volume of the typical Minnesota prescriber of this medication (26). Medicare paid an average of $58.06 per fill, versus $66.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MN average for this medication. 218.4 30-Day Fills standardized to 30-day supplies 6,538 Days of Medication total across all patients in 2023 | |||
| Humira(Cf) PenAdalimumab | 93 | $7,049.32▼ below MN avg | ▲ More than typical |
About Humira(Cf) Pen: Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). Show more ▾ This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis). A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. In 2023, this provider wrote 93 Medicare prescriptions for Humira(Cf) Pen, about 3.7 times the volume of the typical Minnesota prescriber of this medication (25). Medicare paid an average of $7,049.32 per fill, versus $8,516.42 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MN average for this medication. 93 30-Day Fills standardized to 30-day supplies 2,604 Days of Medication total across all patients in 2023 | |||
| Folic Acid | 61 | $10.32 | ▲ More than typical |
About Folic Acid: Folic acid is the man-made form of folate. Show more ▾ Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. In 2023, this provider wrote 61 Medicare prescriptions for Folic Acid, about 3 times the volume of the typical Minnesota prescriber of this medication (20). Medicare paid an average of $10.32 per fill, versus $6.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 169.6 30-Day Fills standardized to 30-day supplies 5,080 Days of Medication total across all patients in 2023 | |||
| Colchicine | 47 | $99.76 | ▲ More than typical |
About Colchicine: This medication is used to prevent or treat gout attacks (flares). Show more ▾ Usually gout symptoms develop suddenly and involve only one or a few joints. The big toe, knee, or ankle joints are most often affected. Gout is caused by too much uric acid in the blood. When uric acid levels in the blood are too high, the uric acid may form hard crystals in your joints. Colchicine works by decreasing swelling and lessening the build up of uric acid crystals that cause pain in the affected joint(s). This medication is also used to prevent attacks of pain in the abdomen, chest, or joints caused by a certain inherited disease (familial Mediterranean fever). It is thought to work by decreasing your body's production of a certain protein (amyloid A) that builds up in people with familial Mediterranean fever. Colchicine is not a pain medication and should not be used to relieve other causes of pain. A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). In 2023, this provider wrote 47 Medicare prescriptions for Colchicine, about 2.6 times the volume of the typical Minnesota prescriber of this medication (18). Medicare paid an average of $99.76 per fill, versus $98.85 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 131.5 30-Day Fills standardized to 30-day supplies 3,945 Days of Medication total across all patients in 2023 | |||
| Azathioprine | 44 | $54.41▼ below MN avg | ▲ More than typical |
About Azathioprine: Azathioprine is used to prevent organ rejection in people who have received a kidney transplant. Show more ▾ It is usually taken along with other medications to allow your new kidney to function normally. Azathioprine is also used to treat rheumatoid arthritis. In this condition, the body's defense system (immune system) attacks healthy joints. Azathioprine belongs to a class of drugs known as immunosuppressants. It works by weakening the immune system to help your body accept the new kidney as if it were your own (in the case of an organ transplant) or to prevent further damage to your joints (in the case of rheumatoid arthritis). Talk to your doctor about the risks and benefits of azathioprine, especially when used by children and young adults. An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) In 2023, this provider wrote 44 Medicare prescriptions for Azathioprine, about 1.7 times the volume of the typical Minnesota prescriber of this medication (26). Medicare paid an average of $54.41 per fill, versus $80.65 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MN average for this medication. 90 30-Day Fills standardized to 30-day supplies 2,678 Days of Medication total across all patients in 2023 | |||
| Enbrel SureclickEtanercept | 42 | $7,389.07▼ below MN avg | ≈ Typical |
About Enbrel Sureclick: This medication is used alone or in combination with an immunosuppressant (such as methotrexate) to treat certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis). Show more ▾ Some brands of this medication are also used to treat a skin condition called psoriasis. These conditions are caused by an overactive immune system (autoimmune disease). The immune system attacks the body's own healthy cells, causing inflammation in the joints and skin. Etanercept controls your body's defensive response by blocking the action of a certain natural substance (TNF) that is used by the immune system. Treatment decreases redness, itching and scaly patches in psoriasis as well as the pain, swelling and stiffness of joints in arthritis. This medication can stop the progression of disease and joint damage, resulting in improved daily functioning and quality of life. This medication treats but does not cure autoimmune diseases. Symptoms usually return within 1 month of stopping the medication. A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. In 2023, this provider wrote 42 Medicare prescriptions for Enbrel Sureclick, about 1.2 times the volume of the typical Minnesota prescriber of this medication (35). Medicare paid an average of $7,389.07 per fill, versus $7,562.60 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MN average for this medication. 42 30-Day Fills standardized to 30-day supplies 1,176 Days of Medication total across all patients in 2023 | |||
| Humira PenAdalimumab | 41 | $7,100.39▼ below MN avg | ▲ More than typical |
About Humira Pen: Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). Show more ▾ This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis). A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. In 2023, this provider wrote 41 Medicare prescriptions for Humira Pen, about 2 times the volume of the typical Minnesota prescriber of this medication (20). Medicare paid an average of $7,100.39 per fill, versus $8,156.14 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MN average for this medication. 41 30-Day Fills standardized to 30-day supplies 1,148 Days of Medication total across all patients in 2023 | |||
| OtezlaApremilast | 32 | $6,979.30 | ▲ More than typical |
About Otezla: This medication is used to treat a certain type of arthritis (psoriatic arthritis). Show more ▾ Apremilast is also used to treat a certain type of skin condition (moderate to severe plaque psoriasis). Apremilast belongs to a class of drugs known as phosphodiesterase 4 (PDE4) inhibitors. For the treatment of psoriatic arthritis, it decreases pain and swelling, and may help improve flexibility in the affected joints. For the treatment of plaque psoriasis, it may help to reduce the redness, thickening, and scaling of the skin that occurs with this condition. Apremilast is also used to treat mouth sores in people who have Behcet's disease. It helps to reduce the pain and improve the healing of these mouth sores. In 2023, this provider wrote 32 Medicare prescriptions for Otezla, about 1.8 times the volume of the typical Minnesota prescriber of this medication (18). Medicare paid an average of $6,979.30 per fill, versus $4,767.56 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 46 30-Day Fills standardized to 30-day supplies 1,378 Days of Medication total across all patients in 2023 | |||
| CimziaCertolizumab Pegol | 26 | $5,895.98▼ below MN avg | ▲ More than typical |
About Cimzia: This medication is used to reduce pain and swelling due to certain inflammatory conditions (such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis). Show more ▾ Some brands may also be used to treat a certain type of spine condition (axial spondyloarthritis) or a certain bowel condition (Crohn's disease). Certolizumab belongs to a class of drugs known as tumor necrosis factor (TNF) blockers. It works by blocking TNF, a substance made by the body that causes inflammation. A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS. In 2023, this provider wrote 26 Medicare prescriptions for Cimzia, about 1.6 times the volume of the typical Minnesota prescriber of this medication (16). Medicare paid an average of $5,895.98 per fill, versus $6,325.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MN average for this medication. 26 30-Day Fills standardized to 30-day supplies 728 Days of Medication total across all patients in 2023 | |||
| Xeljanz XrTofacitinib Citrate | 22 | $5,782.91 | ≈ Typical |
About Xeljanz Xr: Tofacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis-pcJIA). Show more ▾ It helps to decrease pain/tenderness/swelling in the joints. Tofacitinib is also used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. In 2023, this provider wrote 22 Medicare prescriptions for Xeljanz Xr, about 88% of the volume of the typical Minnesota prescriber of this medication (25). Medicare paid an average of $5,782.91 per fill, versus $5,629.34 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2023 | |||
| Pilocarpine Hcl | 21 | $168.98 | ≈ Typical |
About Pilocarpine Hcl: This medication is used to treat symptoms of dry mouth due to a certain immune disease (Sjogren's syndrome) or from saliva gland damage due to radiation treatments of the head/neck for cancer. Show more ▾ Pilocarpine belongs to a class of drugs known as cholinergic agonists. It works by stimulating certain nerves to increase the amount of saliva you produce, making it easier and more comfortable to speak and swallow. A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. In 2023, this provider wrote 21 Medicare prescriptions for Pilocarpine Hcl, about the same volume as the typical Minnesota prescriber of this medication (22). Medicare paid an average of $168.98 per fill, versus $107.33 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 54 30-Day Fills standardized to 30-day supplies 1,610 Days of Medication total across all patients in 2023 | |||
| Mycophenolate Mofetil | 21 | $86.36▼ below MN avg | ≈ Typical |
About Mycophenolate Mofetil: Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted organ (such as kidney, liver, heart). Show more ▾ It belongs to a class of medications called immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own. Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. In 2023, this provider wrote 21 Medicare prescriptions for Mycophenolate Mofetil, about 75% of the volume of the typical Minnesota prescriber of this medication (28). Medicare paid an average of $86.36 per fill, versus $137.94 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MN average for this medication. 46.2 30-Day Fills standardized to 30-day supplies 1,385 Days of Medication total across all patients in 2023 | |||
| Orencia ClickjectAbatacept | 19 | $5,605.55▼ below MN avg | ≈ Typical |
About Orencia Clickject: This medication is used to treat rheumatoid arthritis, a condition in which the body's own defense system (immune system) attacks healthy tissue. Show more ▾ This leads to swelling in the joints, which causes pain and makes it harder to move. Abatacept works by weakening your immune system. This effect helps to slow down joint damage and reduce joint pain and swelling so you can move better. This medication is also used to treat other types of arthritis (such as juvenile idiopathic arthritis, psoriatic arthritis). A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS. In 2023, this provider wrote 19 Medicare prescriptions for Orencia Clickject, about 83% of the volume of the typical Minnesota prescriber of this medication (23). Medicare paid an average of $5,605.55 per fill, versus $5,830.46 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MN average for this medication. 19 30-Day Fills standardized to 30-day supplies 532 Days of Medication total across all patients in 2023 | |||
| Methotrexate SodiumMethotrexate Sodium/Pf | 18 | $13.48▼ below MN avg | ≈ Typical |
About Methotrexate Sodium: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma) or to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. Show more ▾ It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. In 2023, this provider wrote 18 Medicare prescriptions for Methotrexate Sodium, about 78% of the volume of the typical Minnesota prescriber of this medication (23). Medicare paid an average of $13.48 per fill, versus $17.51 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MN average for this medication. 23.2 30-Day Fills standardized to 30-day supplies 619 Days of Medication total across all patients in 2023 | |||
| Enbrel MiniEtanercept | 14 | $7,197.89 | ▼ Less than typical |
About Enbrel Mini: This medication is used alone or in combination with an immunosuppressant (such as methotrexate) to treat certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis). Show more ▾ Some brands of this medication are also used to treat a skin condition called psoriasis. These conditions are caused by an overactive immune system (autoimmune disease). The immune system attacks the body's own healthy cells, causing inflammation in the joints and skin. Etanercept controls your body's defensive response by blocking the action of a certain natural substance (TNF) that is used by the immune system. Treatment decreases redness, itching and scaly patches in psoriasis as well as the pain, swelling and stiffness of joints in arthritis. This medication can stop the progression of disease and joint damage, resulting in improved daily functioning and quality of life. This medication treats but does not cure autoimmune diseases. Symptoms usually return within 1 month of stopping the medication. A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. In 2023, this provider wrote 14 Medicare prescriptions for Enbrel Mini, about 64% of the volume of the typical Minnesota prescriber of this medication (22). Medicare paid an average of $7,197.89 per fill, versus $6,686.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2023 | |||
| Febuxostat | 11 | $534.08 | ▼ Less than typical |
About Febuxostat: Febuxostat is used to lower uric acid levels in people with gout. Show more ▾ Febuxostat works by reducing the amount of uric acid made by the body. An increased uric acid level can cause gout. Because of the risk of very serious heart-related problems and stroke with febuxostat (see also Warning section), febuxostat should be used only after treatment with a medication called allopurinol did not work to lower your uric acid level, caused serious side effects, or is not recommended by your doctor. Febuxostat should be used only if you have symptoms caused by a high blood uric acid level. A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT. In 2023, this provider wrote 11 Medicare prescriptions for Febuxostat, about 69% of the volume of the typical Minnesota prescriber of this medication (16). Medicare paid an average of $534.08 per fill, versus $215.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for ALI SAJJAD MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Rheumatology prescribing approach at this Maplewood, MN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
